Editor-in-Chief: David D. Ho, MD
Paul A. Volberding, MD
William A. Blattner, MD
ISSN: 1525-4135
Online ISSN: 1077-9450
Frequency: 15 issues per year
Ranking: Infectious Diseases 10/70
Immunology 30/144
Impact Factor: 4.394
Featured Supplements



 Guest Editors:

 Jonathan E. Kaplan

Tiffany E. Hamm

April 15, 2015 - Volume 68 - Supplement 3

The Impact of HIV Care and Support Interventions on Key Outcomes in Low- and Middle-Income Countries

This special issue features 14 manuscripts that include evidence reviews and policy implications of HIV care and support interventions.   The series of articles are the result of a U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) convened technical working group comprised of HIV/AIDS experts who examined the impact of current care and support interventions on five outcomes — morbidity, mortality, retention in care, quality of life, and HIV transmission.  This considerable undertaking adds a depth to the HIV care and treatment literature that not only addresses the science, but the practical application of interventions countries need to inform policy decisions and maximize the impact of HIV care and treatment interventions. 

Publication of this supplement was made possible by support from PEPFAR.

Press Release





Guest Editors:

Tisha Wheeler, MSc; R. Cameron Wolf, PhD, MSc; Laurent Kapesa, MD, MPH; and Alison Surdo Cheng

March 1, 2015 - Volume 68 - Supplement 2

HIV Risks and Vulnerabilities among Key Populations in West and Central Africa-Evidence to Inform HIV Prevention, Treatment, and Care

This special issue features 23 manuscripts on key populations including men who have sex with men, female sex workers, and people who inject drugs from West and Central Africa. The manuscripts represent data from 11 different countries throughout the region and include quantitative and qualitative analysis, mathematical modeling studies, and comprehensive reviews.  Over 100 authors contributed to this work from 18 different countries including 4 high income and 14 low and middle income countries. 

Publication of this supplement was made possible by the generous support of the American people through the United States Agency for International Development (USAID) West Africa Regional Office and Office of HIV and AIDS, together with the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)’s Research to Prevention (R2P) Project and Linkages Across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project ;  the Foundation for AIDS Research (amfAR); and the Johns Hopkins University Center for AIDS Research, a National Institutes of Health (NIH) funded program, which is co-funded by the following NIH institutes and centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR.   The contents are the responsibility of the authors and do not necessarily reflect official views of USAID, PEPFAR, NIH, or the United States Government.

Press Release: English / French

Current Issue Highlights


PLEASE NOTE: There will be system maintenance on Thursday, March 26, 2015 [12:00am EST, 11pm CST; 9pm PST]. During this time this journal site will be unavailable for one hour. Thank you for your patience during this time.


Open Access

Information on

Open Access in JAIDS

2014 Top Reviewers

Basic Science 

Clinical Science 

Epi & Prevention 





Jean Joel

Bigna Rim























Shahul H.


* Editorial Board Member

Thank you for

your outstanding service to JAIDS!

Webinar Panel Discussion

Strategic Roles for Health Communication in Combination HIV Prevention and Care Programs

Co-sponsored by Johns Hopkins’ Center for AIDS Research and Center for Communication Programs 


Webinar recording available


Read related content in Health Communication Strategies in Combination HIV Prevention and Care Programs

JAIDS Supplement, Vol. 66 Supplement 3

Journal Announcement

New Focus Area: Hepatitis B virus (HBV) and Hepatitis C virus (HCV)

JAIDS is now accepting manuscripts for a new focus area of interest: HBV and HCV  

The investment in HIV research has allowed us to make huge advances in controlling a formerly brutal epidemic. Now, what we've learned from HIV is being applied to hepatitis viruses, both HBV and especially HCV where curative treatments are on the verge of transforming that epidemic as well. JAIDS believes there is a clear synergy in these research efforts and that on all levels these research efforts are vital to share across the boundaries of interest of specific viral infections. JAIDS looks forward to publishing the best of this work and calls for manuscripts in HCV and HBV research as well as in ongoing work against HIV infection. 

View the latest Instructions to Authors.

Advances Relating to HIV Infection

Summaries of posters and presentations from ICAAC 2013

September 10 - 13, 2013

Denver, Colorado


Associate Director of the Institute of Human Virology, Director, Division of Epidemiology and Prevention

The University of Maryland School of Medicine Institute of Human Virology Division seeks a visionary leader with skills to manage and guide the Division of Epidemiology and Prevention and, as Associate Director, lead the mission of promoting the growth of the Institute and its multidisciplinary and translational research mission targeting chronic viral diseases, especially HIV/AIDS, and cancer especially virally linked cancer.

Position Announcement